According to updated guidelines published by NICE, patients newly diagnosed with glaucoma and ocular...
Read moreThis reforms have been welcomed by the industry as they should support faster access to medicines as...
Read moreThe changes cover how topics are chosen, the steps and stages in each evaluation and how evidence is...
Read moreThe National Institute for Health and Care Excellence (NICE) on 31st January 2022 published its new ...
Read moreWe hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreIs the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...
Read moreThe purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more